Ad is loading...
GQLVX
Price
$14.57
Change
-$0.11 (-0.75%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

GQLVX vs VIVIX

Header iconGQLVX vs VIVIX Comparison
Open Charts GQLVX vs VIVIXBanner chart's image
Glenmede Quant US Large Cap Value Equity
Price$14.57
Change-$0.11 (-0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
GQLVX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQLVX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQLVX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. GQLVX (2.14M). VIVIX pays higher dividends than GQLVX: VIVIX (2.37) vs GQLVX (1.65). GQLVX was incepted earlier than VIVIX: GQLVX (7 years) vs VIVIX (26 years). GQLVX is a more actively managed with annual turnover of: 81.00 vs. VIVIX (10.00). GQLVX has a lower initial minimum investment than VIVIX: GQLVX (0) vs VIVIX (5000000). VIVIX (25.54) and GQLVX (24.86) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. GQLVX (48.10).
GQLVXVIVIXGQLVX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years26 years-
Gain YTD16.12517.92290%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.14M184B0%
Annual Yield % from dividends1.652.3770%
Returns for 1 year24.8625.5497%
Returns for 3 years14.6021.5768%
Returns for 5 years48.1050.7995%
Returns for 10 yearsN/A110.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXR164.561.13
+0.69%
Extra Space Storage
PALT1.83N/A
N/A
Paltalk
AOMR9.80-0.06
-0.61%
Angel Oak Mortgage REIT
DLO9.89-0.31
-3.04%
DLocal Limited
GYRE13.12-0.72
-5.20%
Gyre Therapeutics